How Dexcom and Abbott go beyond diabetes

According to the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes. That’s just over 11% of the entire population.

The body of a diabetic does not produce enough insulin or none at all. People with the disease should monitor their blood sugar regularly. This has traditionally been done with glucometers, which diabetics use to prick their fingers over and over again for drops of blood. But over the past decade, technologies such as continuous glucose monitoring have proliferated.

Abbott And Dexcom are the two most dominant players in the space. Both companies experienced increased growth.

The technology is also being marketed by several health and wellness apps, as many companies see benefits for those without diabetes.

CNBC spoke with Abbott and Dexcom about continuous blood glucose monitor technology and how they see it developing.

Watch the video to learn more.